Regulatory Basics for Medical Devices - Medical Device Courses Forum

Who Should Be Responsible for Regulatory Basics?

ATMEH.NJIT — Fri, 26 Sep 2025 14:40:39 +0000

In my opinion, engineers should definitely have at least a basic understanding of regulations. Even though Regulatory Affairs professionals are the ones who specialize in compliance, I don’t think engineers can just ignore it. If we design something that doesn’t line up with FDA or ISO requirements, then we’ve wasted time, money, and effort on something that may never be approved. To me, that feels like a huge risk that could be avoided if engineers kept compliance in mind from the start.

That being said, I don’t think engineers need to become experts in Regulatory Affairs either. If we spend all our time focused on compliance rules, it takes away from the creative side of design and problem-solving, which is where engineers add the most value. I think the best approach is a balance: engineers should know enough to design with compliance in mind, but the detailed rules and submissions should stay in the hands of specialists.

Personally, I believe smaller companies might need engineers to handle more of the compliance work, while larger companies can afford to keep those roles separate. But no matter the size, I think engineers should at least understand the basics so we’re not creating designs that regulatory teams later have to reject.

What do you think: should engineers take on more of the responsibility for regulations, or is it better for them to focus on design and let specialists handle compliance?

Should Engineers Worry About Compliance From the Start?

ATMEH.NJIT — Thu, 25 Sep 2025 14:50:17 +0000

I’ve noticed that some people suggest engineers should prioritize compliance from the outset, while others believe creativity should take precedence and compliance can be addressed later. I can see both sides of this. Thinking about FDA rules early might save time in the long run because you won’t design something that has to be completely redone later. It could also make the process smoother by avoiding surprises when it’s time for approval.

But at the same time, I worry that if compliance takes over too soon, it could shut down some of the most creative ideas before they even have a chance to be explored. Engineers might start limiting themselves, thinking, “This won’t pass anyway, so why bother?” Some of the best innovations probably come from ideas that looked risky at first but were shaped into something compliant later.

It feels like this is really about finding the right balance. Perhaps projects should begin with a “wide-open” creative phase, where new ideas can flow, followed by a reality check where the team incorporates regulatory considerations. That way, creativity isn’t lost, but you also don’t end up with a device that can’t be approved.

What do you think is better for the device development process — giving engineers full freedom at the start and adjusting later, or building compliance into every step from the very beginning? And do you think the best answer might depend on whether it’s a small startup or a big company with more resources?

FDA Classes: Reform needed or fine as is?

JacobChabuel — Thu, 25 Sep 2025 14:50:01 +0000

The FDA medical device classification system (Class 1, 2 and 3) have been in place for many years and is based upon the level of risk a device poses to a patient. However, with the advance of technology, we are now seeing devices that may not fit into these classification categories due to the complexities of modern innovation. Software based tools for example may not fit well into the traditional categories outlined by the classification system, but can still significantly contribute to patient outcomes. This begs the question whether existing classification frameworks are sufficient enough to keep up with new innovations, or if it requires some level of reform.

Do you think the FDAs classification system is outdated, and if so, what changes need to be made to make it more effective for newer developing products? Conversely, do you believe that reform could introduce any unnecessary risks or uncertainty in the system? Let me know your thoughts on the topic.

Are Regulations Helping Innovation or Slowing It Down?

ATMEH.NJIT — Thu, 25 Sep 2025 02:26:08 +0000

Regulations are clearly important for protecting patients, but sometimes I wonder if they also slow down new ideas from reaching the market. For example, small companies might have innovative device designs, but the cost and time required to obtain FDA approval can hold them back. On the other hand, without strong regulations, unsafe devices could easily reach patients and cause harm.

So I’m curious — do you think regulations mostly help innovation by keeping things safe and organized, or do they slow it down by making the process too hard for new ideas to grow? What could be the optimal point for both sides?

How to start career in regulatory area (no industry exp yet)

Giang — Mon, 30 Sep 2024 02:52:10 +0000

It appeared very interesting to me on the first lecture that positions in regulatory is in demand. Just want to ask for insights from those who are in it or know more information: how do you actually start a career as a regulatory affairs position, especially with the background of being in the lab and doing research? is there a certificate needed? Coursework requirement at all? Or just try my best to look and apply for a fresher position and get trained? I believe there will be a lot of writing, would it get boring if you're writing to fulfill certain requirement again and again for different products?

Role of clinical trials for medical devices & pharmaceuticals

Samiha Khan — Sun, 29 Sep 2024 19:53:31 +0000

Clinical trials are necessary for the approval of both medicines and medical devices. However, there are major variations in the design, scale, and scope of device trials. Identifying the differences in clinical trial prerequisites according to device risk class and planned use will help organizations in crafting more efficient study designs and submissions. In this context, what role do clinical trials play in the approval process for medical devices, and how do the requirements differ from those of pharmaceuticals?

Balancing Innovation and Safety

Zeinab Amoabediny — Wed, 25 Sep 2024 20:39:05 +0000

The Food and Drug Administration (FDA) plays an important role in ensuring the safety and effectiveness of medical devices in the United States. The FDA's regulatory framework is designed to protect public health by rigorously evaluating medical devices before they enter the market. This process involves classifying devices into different categories based on the level of risk they present. Understanding these classifications and the FDA's responsibilities provides critical insight into how medical devices are regulated.

Based on this week's lecture, my question is: What challenges does the FDA face in balancing innovation with safety and effectiveness in the medical device industry? How do these regulations impact both manufacturers and public health?

Punishment for Failing FDA Audits

rm829 — Sat, 30 Sep 2023 19:36:16 +0000

As someone who works for a medical device company with a class III medical device, our company is required to be audited every two years for compliance. Through the auditing process, there are many steps that need to be taken regarding the control of the company's efforts to keep products from failing FDA requirements. My question involves the punishment for minor errors in the system and what the repercussions for this should be. For example, let's say a company has no major nonconformances regarding their main product (which is the class III medical device), but has a couple minor errors regarding labeling or paperwork for separate components/areas which have to be note on the FDA audit paperwork. If these errors were to be present, what can happen to the business as a result? Even though there are small errors completely unrelated to the medical device itself, how should the FDA react towards the company?

Role of Industry Standards for Regulatory

hayderk — Sat, 30 Sep 2023 17:52:01 +0000

Technological advancements are more often than not employed into industry standards and procedures. As a result practices have changed to accommodate newer times, and instances such as the 510(k) need revision. That got me thinking of how industry-specific standards in regulatory compliance contribute to a more streamlined and effective regulatory landscape? Moreso How does technology help/inhibit regulatory procedures? In our ever digital age are some older practices best kept the same as they are now?

FDA biased?

atk27@njit.edu — Sat, 30 Sep 2023 17:51:53 +0000

We know that a large sum of the money(about 70%) for the FDA comes from the user fees paid by pharmaceutical and biotechnology companies. These fees are paid by companies when they submit applications for drug approvals and are intended to help expedite the FDA's review process. Under this arrangement, pharmaceutical companies pay approximately $2 million to submit drug data to the FDA for an expedited review of their drugs. So what my concern is that this might incentivize the FDA to be biased towards the company.

They also have industry professionals on advisory committees to the fees they pay to have new drugs reviewed so how much bias is there really within the FDA? If there is bias, how can the FDA make sure that the needs of the patient is put first before the funding from these companies?